Application 017970
- Type
- NDA
- Sponsor
- ASTRAZENECA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NOLVADEX | TAMOXIFEN CITRATE | TABLET;ORAL | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | NOLVADEX | TAMOXIFEN CITRATE | TABLET;ORAL | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017970-001 | NOLVADEX | TAMOXIFEN CITRATE | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N017970-002 | NOLVADEX | TAMOXIFEN CITRATE | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1994-03-21 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N017970-001 | NOLVADEX | EQ 10MG BASE | TABLET / ORAL | RLD, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N017970-002 | NOLVADEX | EQ 20MG BASE | TABLET / ORAL | RLD | 1994-03-21 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N017970-001 | NOLVADEX | EQ 10MG BASE | TABLET / ORAL | RLD, Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N017970-002 | NOLVADEX | EQ 20MG BASE | TABLET / ORAL | RLD | 1994-03-21 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N017970-001 | NOLVADEX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N017970-002 | NOLVADEX | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 1994-03-21 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tamoxifen Citrate | TAMOXIFEN CITRATE | NuCare Pharmaceuticals, Inc. | 509f8ba3-214d-aec8-e063-6294a90af498 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Bryant Ranch Prepack | 8c0eb763-420a-4106-ba56-526b53a7f72b | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | A-S Medication Solutions | 8d731e7e-3b04-49a2-a0f6-3779422174cc | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Actavis Pharma, Inc. | 9b8a4211-120f-4981-ad69-928accb97637 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Mayne Pharma Commercial LLC | c82205a3-ae0c-4ce5-b04b-9581cd8c70d4 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | A-S Medication Solutions | 716657e8-d809-4671-87bc-8d10ef69a071 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Bryant Ranch Prepack | 9b4a8abc-6e56-40c5-a826-1d1f3c0786e1 | 2024-11-07 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | NuCare Pharmaceuticals,Inc. | a5615dbb-3c5e-6ccc-e053-2995a90ab698 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Dr. Reddy's Labratories Inc. | c6c6a643-57d6-7ea5-7da0-e8a66802468a | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Bryant Ranch Prepack | feb96056-79f5-4024-ab0e-fdbb8d4ab862 | 2024-01-19 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Proficient Rx LP | bb53eeb7-83fc-469e-b9e3-df5f27bfec7b | 2022-09-01 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| SOLTAMOX | TAMOXIFEN CITRATE | Mayne Pharma | 1e6ff055-590c-41e6-9530-1fdf04cdbd02 | 2021-11-29 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Mylan Pharmaceuticals Inc. | 7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0 | 2021-07-02 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Aurobindo Pharma Limited | a596c715-8e30-43c1-aba3-4fe5de6729fa | 2020-08-14 | Boxed warning, Warnings, Adverse reactions | TAMOXIFEN CITRATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 53729 | SUPPL | 2018-04-18 |
| 43602 | ORIG | 2009-11-19 |
| 40766 | SUPPL | 2009-09-14 |
| 768 | SUPPL | 2006-03-23 |
| 33386 | SUPPL | 2006-03-14 |
| 33385 | SUPPL | 2005-03-23 |
| 767 | SUPPL | 2005-03-23 |
| 11105 | SUPPL | 2004-12-30 |
| 766 | SUPPL | 2004-12-30 |
| 33384 | SUPPL | 2004-06-10 |
| 13972 | SUPPL | 2004-06-10 |
| 20100 | SUPPL | 2003-07-05 |
| 20099 | SUPPL | 2003-07-05 |
| 11103 | SUPPL | 2003-06-22 |
| 764 | SUPPL | 2003-06-22 |
| 40769 | SUPPL | 2003-03-07 |
| 13971 | SUPPL | 2002-08-30 |
| 11104 | SUPPL | 2002-08-30 |
| 33383 | SUPPL | 2002-05-16 |
| 33381 | SUPPL | 2002-05-16 |
| 13968 | SUPPL | 2002-05-16 |
| 11101 | SUPPL | 2002-05-16 |
| 765 | SUPPL | 2002-05-16 |
| 763 | SUPPL | 2002-05-16 |
| 40768 | SUPPL | 2000-06-29 |
| 33382 | SUPPL | 2000-06-29 |
| 13970 | SUPPL | 2000-06-29 |
| 40767 | SUPPL | 1998-10-29 |
| 33380 | SUPPL | 1998-10-29 |
| 20098 | SUPPL | 1998-10-29 |
| 13969 | SUPPL | 1998-10-29 |
| 11102 | SUPPL | 1998-10-29 |
| 762 | SUPPL | 1998-10-29 |